Skip to content

Clinical trials

Completed Fragile X Syndrome trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fragile X Syndrome Status: Completed Country / region: Canada Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20111
20121
20161
20182
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Université de Sherbrooke2
FRAXA Research Foundation1
Hoffmann-La Roche1
University of Alberta1
University of California, Davis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fragile X Syndrome8
Chromosome Disorders2
Congenital Abnormalities2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Intellectual Disability2
Nervous System Diseases2
Neurobehavioral Manifestations2
Sex Chromosome Disorders2
X-Linked Intellectual Disability2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.